Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Bupropion and Counseling for Smoking Cessation
NCT00087880Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Dec 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupropion in Tobacco Use Disorder (TUD) (5 arms), sponsored by National Institute on Drug Abuse. Primary endpoint: Smoking Behavior at 104 weeks. Started Dec 2002; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00087880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087880.